NaomiHardyMD

Cytopathology, Dermatopathology, Anatomic Pathology, Clinical Pathology

Pathologist

Dr. Hardy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Dr. Naomi Hardy is a pathologist at Main Line Health Pathology Associates in Wynnewood, PA and is affiliated with Lankenau Medical Center and Bryn Mawr Hospital. She received her medical degree from Geisinger Commonwealth School of Medicine. She specializes in cytopathology, dermatopathology, anatomic pathology, and clinical pathology. She has more than 20 publications and over 50 citations.

University of Texas Medical Branch HospitalsFellowship, Dermatopathology, 2023 - 2024
University of MarylandFellowship, Cytopathology, 2021 - 2022
University of MarylandResidency, Pathology-Anatomic and Clinical, 2017 - 2021
University of MarylandChief Residency, Pathology-Anatomic and Clinical, 2019 - 2020
Commonwealth Medical CollegeClass of 2017
Brandeis UniversityBS, Biology and Neuroscience, 2007 - 2011

PubMed

1 citations
Cytologic features of metastatic epithelioid uterine leiomyosarcoma to the pancreas.
Naomi L Hardy, Andrew Canakis, Paul N Staats, Peter Darwin, Teklu Legesse
Diagnostic Cytopathology. 2023-01-01
Pathology Trainees Gain Clinical Pathology Experience as Lab Consultants Through Auditing Myeloid Mutation Panel Send-Out Tests: Hitting Two Birds With One Stone?
Naomi L Hardy, Jonathan Jacobs, Kristin Mullins, Robert Christenson, Thoko Cox
Archives of Pathology & Laboratory Medicine. 2022-10-01
1 citations
Pancreatic serous cystadenoma with a positive octreotide scan.
Andrew Canakis, Varun Kesar, Naomi Hardy, Teklu B Legesse, Peter Darwin
Gastrointestinal Endoscopy. 2022-06-01

Journal Articles

When the horse has stripes: CNS Blastomycosis presenting as a ring-enhancing lesion in an immunocompetent patient.
Hardy, N., Markidan, J., Luethy, P., Ames, H., American Journal of Surgical Pathology: Reviews & Reports, 3/2020
Hypercalcemia of Malignancy: Simultaneous Elevation of Parathyroid Hormone-related Peptide and 1,25 Dihydroxyvitamin D in Sarcoma
Kim, D., Miller, A., Li, A., Hardy, N., Silver, K., American Association of Clinical Endocrinologists Clinical Case Reports, 2020
A Guide to Differentiating Thrombotic Microangiopathies through a Case of Catastrophic Antiphospholipid Syndrome (CAPS)
Hardy, N., Stashek, K., AJSP: Reviews and Reports, 2020
A 64-Year-Old Woman with Posttransplant Hepatitis.
Hardy, N., Twaddell, William., American Journal of Surgical Pathology: Reviews & Reports, 10/2018
Join now to see all

Abstracts/Posters

The Impact of Subtyping and Histologic Grading on the Prognosis of Epithelioid Pleural Mesothelioma
Hardy, N., Richards, S., Fanaroff, S., Culligan, M., Friedberg, J., Burke, A, United States and Canadian Academy of Pathology, Virtual, 3/2021
Predictors of Upgrading Diffuse Malignant Mesothelioma from Epithelioid to Biphasic from Initial Sampling to Extended Pleural Decortication
Fanaroff, R., Markidan, J., Hardy, N., Culligan, M., Glass, E., Friedberg, J., Burke, A, United States and Canadian Academy of Pathology, Virtual, 3/2021
Assessing Impostor Syndrome in an Academic Pathology Program
Hardy, N., Koka, RM., Stashek, K, Association of Pathology Chairs, Virtual, 7/2020
A residency educational intervention to refine the evaluation of dysplasia in Barrett’s esophagus.
Hardy, N., Stashek, K., Twaddell, W., United States and Canadian Academy of Pathology (USCAP), Los Angeles, CA, 3/2020
Join now to see all